New Blood Glucose Meter Designed to Control Cross-Contamination in Hospitals

Abbott has received clearance from the FDA for the FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, a blood glucose monitoring system designed to address the needs of hospitalists.

Key features of Abbott’s FreeStyle Precision Pro system include:

Individually foil-wrapped test strips to help reduce the risk of test strip cross-contamination of blood and bacteria. The device conforms to FDA requirements for cleaning and disinfection, which require devices to be disinfected after each use. The FreeStyle Precision Pro Meter also offers a replaceable strip port that can be removed for replacement on-site.
Real-time, dual-band wireless communication between the handheld meter at the patient bedside and the hospital information system, giving clinical staff immediate access to patient test results throughout their facility. The dual-band wireless technology enables the flexibility of wireless access within a hospital’s Wi-Fi-enabled network when properly configured. The system is designed so that clinical operators need not interrupt their busy workflow to conduct routine docking or attach a data cable to download patient results, saving time while also providing access to real-time data. This helps ensure immediate access to test results through the hospital’s electronic medical record system, and to facilitate clinical decision whenever it is needed.
A new algorithm to correct for hematocrit interference. The test process occurs in five seconds for prompt and accurate delivery of test results.
Technology to read newer 2D barcodes, which are becoming more prevalent in healthcare identification systems.

For more information call (847) 937-6100 or visit Abbott.com.

Want to read more?